NDC 72934-1014

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2%

Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2%

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Spironolactone.

Product ID72934-1014_8889353c-eb02-f8f3-e053-2995a90a60d4
NDC72934-1014
Product TypeHuman Prescription Drug
Proprietary NameBENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2%
Generic NameBenzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-11
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE; SPIRONOLACTONE
Active Ingredient Strength5 g/100g; g/100g; g/100g; g/100g
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1014-2

30 g in 1 BOTTLE, PUMP (72934-1014-2)
Marketing Start Date2019-05-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1014-2 [72934101402]

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-11

Drug Details

Active Ingredients

IngredientStrength
BENZOYL PEROXIDE5 g/100g

OpenFDA Data

SPL SET ID:8889353c-eb01-f8f3-e053-2995a90a60d4
Manufacturer
UNII

Pharmacological Class

  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Aldosterone Antagonist [EPC]
  • Aldosterone Antagonists [MoA]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Aldosterone Antagonist [EPC]
  • Aldosterone Antagonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.